{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:51:50Z","timestamp":1768441910091,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GIMEMA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12955-018-0953-4","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T08:51:53Z","timestamp":1529311913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed\/refractory multiple myeloma: the CLARITY study protocol"],"prefix":"10.1186","volume":"16","author":[{"given":"Fabio","family":"Efficace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cottone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Niscola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampia","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Caravita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Cavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"953_CR1","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1182\/blood-2014-11-568923","volume":"125","author":"AK Nooka","year":"2015","unstructured":"Nooka AK, Kastritis E, Dimopoulos MA, Lonial S. Treatment options for relapsed and refractory multiple myeloma. Blood. 2015;125:3085\u201399.","journal-title":"Blood"},{"key":"953_CR2","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","volume":"117","author":"SV Rajkumar","year":"2011","unstructured":"Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the international myeloma workshop consensus panel 1. Blood. 2011;117:4691\u20135.","journal-title":"Blood"},{"key":"953_CR3","doi-asserted-by":"crossref","unstructured":"Sparano F, Cavo M, Niscola P, Caravita T, Efficace F. Patient-reported outcomes in relapsed\/refractory multiple myeloma: a systematic review. Support Care Cancer. 2018;26:2075\u201390.","DOI":"10.1007\/s00520-018-4137-x"},{"key":"953_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/leu.2013.185","volume":"27","author":"P Sonneveld","year":"2013","unstructured":"Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia. 2013;27:1959\u201369.","journal-title":"Leukemia"},{"issue":"19","key":"953_CR5","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1182\/blood-2015-05-612960","volume":"126","author":"A Larocca","year":"2015","unstructured":"Larocca A, Palumbo A. How I treat fragile myeloma patients. Blood. 2015;126(19):2179\u201385.","journal-title":"Blood"},{"key":"953_CR6","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report. Blood. 2015;125:2068\u201374.","journal-title":"Blood"},{"key":"953_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20\u201330.","journal-title":"Gerontologist"},{"key":"953_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist"},{"key":"953_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"953_CR10","unstructured":"US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: US Department of Health and Human Services Food and Drug Administration; 2009. Accessed 19 Feb 2018 \n                    http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf"},{"key":"953_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrclinonc.2015.29","volume":"12","author":"AA Secord","year":"2015","unstructured":"Secord AA, Coleman RL, Havrilesky LJ, Abernethy AP, Samsa GP, Cella D. Patient-reported outcomes as end points and outcome indicators in solid tumours. Nat Rev Clin Oncol. 2015;12:358\u201370.","journal-title":"Nat Rev Clin Oncol"},{"key":"953_CR12","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2006.07.4674","volume":"25","author":"CC Gotay","year":"2007","unstructured":"Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, et al. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007;25:2093\u20139.","journal-title":"J Clin Oncol"},{"key":"953_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.2005.04.0824","volume":"24","author":"D Dubois","year":"2006","unstructured":"Dubois D, Dhawan R, van de Velde H, Esseltine D, Gupta S, Viala M, et al. Descriptive and prognostic value of patient-reported outcomes: the Bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol. 2006;24:976\u201382.","journal-title":"J Clin Oncol"},{"key":"953_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00520-014-2577-5","volume":"23","author":"O Husson","year":"2015","unstructured":"Husson O, Mols F, van de Poll-Franse L, de Vries J, Schep G, Thong MS. Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry. Support Care Cancer. 2015;23:2165\u201374.","journal-title":"Support Care Cancer"},{"key":"953_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S1470-2045(15)00206-5","volume":"16","author":"F Efficace","year":"2015","unstructured":"Efficace F, Gaidano G, Breccia M, Voso MT, Cottone F, Angelucci E, et al. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. Lancet Oncol. 2015;16:1506\u201314.","journal-title":"Lancet Oncol"},{"key":"953_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJMp1109283","volume":"366","author":"MJ Barry","year":"2012","unstructured":"Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012;366:780\u20131.","journal-title":"N Engl J Med"},{"key":"953_CR17","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.1992.03480160079038","volume":"267","author":"EJ Emanuel","year":"1992","unstructured":"Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267:2221\u20136.","journal-title":"JAMA"},{"key":"953_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7326\/0003-4819-102-4-520","volume":"102","author":"S Greenfield","year":"1985","unstructured":"Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med. 1985;102:520\u20138.","journal-title":"Ann Intern Med"},{"key":"953_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/BF02595921","volume":"3","author":"S Greenfield","year":"1988","unstructured":"Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients\u2019 participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3:448\u201357.","journal-title":"J Gen Intern Med"},{"key":"953_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/08964289809596384","volume":"24","author":"J Benbassat","year":"1998","unstructured":"Benbassat J, Pilpel D, Tidhar M. Patients\u2019 preferences for participation in clinical decision making: a review of published surveys. Behav Med. 1998;24:81\u20138.","journal-title":"Behav Med"},{"key":"953_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/sj.leu.2403289","volume":"18","author":"MA Sekeres","year":"2004","unstructured":"Sekeres MA, Stone RM, Zahrieh D, Neuberg D, Morrison V, De Angelo DJ, et al. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2004;18:809\u201316.","journal-title":"Leukemia"},{"key":"953_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejon.2008.03.004","volume":"12","author":"G Hubbard","year":"2008","unstructured":"Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs. 2008;12:299\u2013318.","journal-title":"Eur J Oncol Nurs"},{"key":"953_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/pon.1215","volume":"17","author":"BA Vogel","year":"2008","unstructured":"Vogel BA, Helmes AW, Hasenburg A. Concordance between patients\u2019 desired and actual decision-making roles in breast cancer care. Psychooncology. 2008;17:182\u20139.","journal-title":"Psychooncology"},{"key":"953_CR24","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1200\/JCO.2007.11.1922","volume":"25","author":"EB Elkin","year":"2007","unstructured":"Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients\u2019 preferences and their physicians\u2019 perceptions. J Clin Oncol. 2007;25:5275\u201380.","journal-title":"J Clin Oncol"},{"key":"953_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/annonc\/mdt557","volume":"25","author":"F Efficace","year":"2014","unstructured":"Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, et al. Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. Ann Oncol. 2014;25:447\u201354.","journal-title":"Ann Oncol"},{"key":"953_CR26","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1136\/bmj.e256","volume":"344","author":"AM Stiggelbout","year":"2012","unstructured":"Stiggelbout AM, Van der Weijden T, De Wit MP, Frosch D, Legare F, Montori VM, et al. Shared decision making: really putting patients at the Centre of healthcare. BMJ. 2012;344:e256.","journal-title":"BMJ"},{"key":"953_CR27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.1997.03540420081039","volume":"277","author":"LF Degner","year":"1997","unstructured":"Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O'Neil J, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485\u201392.","journal-title":"JAMA"},{"key":"953_CR28","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2004.09.069","volume":"22","author":"NK Janz","year":"2004","unstructured":"Janz NK, Wren PA, Copeland LA, Lowery JC, Goldfarb SL, Wilkins EG. Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol. 2004;22:3091\u20138.","journal-title":"J Clin Oncol"},{"key":"953_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1188\/14.ONF.411-419","volume":"41","author":"JD Tariman","year":"2014","unstructured":"Tariman JD, Doorenbos A, Schepp KG, Singhal S, Berry DL. Older adults newly diagnosed with symptomatic myeloma and treatment decision making. Oncol Nurs Forum. 2014;41:411\u20139.","journal-title":"Oncol Nurs Forum"},{"key":"953_CR30","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1200\/JCO.2014.55.1028","volume":"32","author":"TM Wildes","year":"2014","unstructured":"Wildes TM, Rosko A, Tuchman SA. Multiple myeloma in the older adult: better prospects, more challenges. J Clin Oncol. 2014;32:2531\u201340.","journal-title":"J Clin Oncol"},{"key":"953_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jama.290.1.98","volume":"290","author":"EB Lamont","year":"2003","unstructured":"Lamont EB, Christakis NA. Complexities in prognostication in advanced cancer: \u201cto help them live their lives the way they want to\u201d. JAMA. 2003;290:98\u2013104.","journal-title":"JAMA"},{"key":"953_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/cncr.23713","volume":"113","author":"DK McInnes","year":"2008","unstructured":"McInnes DK, Cleary PD, Stein KD, Ding L, Mehta CC, Ayanian JZ. Perceptions of cancer-related information among cancer survivors: a report from the American Cancer Society's studies of Cancer survivors. Cancer. 2008;113:1471\u20139.","journal-title":"Cancer"},{"key":"953_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/annonc\/mdq413","volume":"22","author":"O Husson","year":"2011","unstructured":"Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22:761\u201372.","journal-title":"Ann Oncol"},{"key":"953_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2702.1999.00296.x","volume":"8","author":"ME Mills","year":"1999","unstructured":"Mills ME, Sullivan K. The importance of information giving for patients newly diagnosed with cancer: a review of the literature. J Clin Nurs. 1999;8:631\u201342.","journal-title":"J Clin Nurs"},{"key":"953_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/pon.3514","volume":"23","author":"O Husson","year":"2014","unstructured":"Husson O, Mols F, Oranje WA, Haak HR, Nieuwlaat WA, Netea-Maier RT, et al. Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry. Psychooncology. 2014;23:946\u201352.","journal-title":"Psychooncology"},{"key":"953_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"953_CR37","first-page":"21","volume":"29","author":"LF Degner","year":"1997","unstructured":"Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29:21\u201343.","journal-title":"Can J Nurs Res"},{"key":"953_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0895-4356(92)90110-9","volume":"45","author":"LF Degner","year":"1992","unstructured":"Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992;45:941\u201350.","journal-title":"J Clin Epidemiol"},{"key":"953_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"953_CR40","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","volume":"43","author":"K Cocks","year":"2007","unstructured":"Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe E, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670\u20138.","journal-title":"Eur J Cancer"},{"key":"953_CR41","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ejca.2010.06.118","volume":"46","author":"JI Arraras","year":"2010","unstructured":"Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini A, et al. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer. 2010;46:2726\u201338.","journal-title":"Eur J Cancer"},{"key":"953_CR42","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jpainsymman.2013.06.010","volume":"47","author":"A Noguera","year":"2014","unstructured":"Noguera A, Yennurajalingam S, Torres-Vigil I, Parsons HA, Duarte ER, Palma A, et al. Decisional control preferences, disclosure of information preferences, and satisfaction among Hispanic patients with advanced cancer. J Pain Symptom Manag. 2014;47:896\u2013905.","journal-title":"J Pain Symptom Manag"},{"key":"953_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","volume":"46","author":"E Boland","year":"2013","unstructured":"Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manag. 2013;46:671\u201380.","journal-title":"J Pain Symptom Manag"},{"key":"953_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1411321","volume":"372","author":"AK Stewart","year":"2015","unstructured":"Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Spicka I, Oriol A, et al. Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med. 2015;372:142\u201352.","journal-title":"N Engl J Med"},{"key":"953_CR45","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/sim.1358","volume":"21","author":"K Van Steen","year":"2002","unstructured":"Van Steen K, Curran D, Kramer J, Molenberghs G, Van Vreckem A, Bottomley A, et al. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection. Stat Med. 2002;21:3865\u201384.","journal-title":"Stat Med"},{"key":"953_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/sim.4780080702","volume":"8","author":"DG Altman","year":"1989","unstructured":"Altman DG, Andersen PK. Bootstrap investigation of the stability of a cox regression model. Stat Med. 1989;8:771\u201383.","journal-title":"Stat Med"},{"key":"953_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of Cancer quality of life questionnaire Core 30. J Clin Oncol. 2011;29:89\u201396.","journal-title":"J Clin Oncol"},{"key":"953_CR48","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K, King MT, Velikova G, de Castro G Jr, Martyn St-James M, Fayers PM, et al. Evidence-based guidelines for interpreting change scores for the European organisation for the research and treatment of Cancer quality of life questionnaire Core 30. Eur J Cancer. 2012;48:1713\u201321.","journal-title":"Eur J Cancer"},{"key":"953_CR49","unstructured":"Fairclough DL. Design and analysis of quality of life studies in clinical trials, second edition. Boca Raton: Chapman & Hall\/CRC; 2010."},{"key":"953_CR50","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.ejca.2010.07.023","volume":"46","author":"F Bonnetain","year":"2010","unstructured":"Bonnetain F, Dahan L, Maillard E, Ychou M, Mitry E, Hammel P, et al. Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer. 2010;46:2753\u201362.","journal-title":"Eur J Cancer"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-018-0953-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T19:20:45Z","timestamp":1560799245000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-018-0953-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1186\/s12955-018-0953-4","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"14 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study will be conducted in accordance with the principles of Good Clinical Practice and the protocol was approved by the University \u2018Sapienza\u2019 Ethics Committee in July 2017.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Fabio Efficace: Consultancy for Seattle Genetics, TEVA, Amgen and Incyte; Research funding: Lundbeck, TEVA and Amgen.Tommaso Caravita: Advisory Board for Celgene, JJ, Amgen, Takeda, BMS; Travel grant from Celgene, JJ, Amgen; Funding from Celgene; Speaker for Siemens.Maria Teresa Petrucci: Honoraria for Celgene, Janssen-Cilag, Takeda, Amgen and BMS.Michele Cavo: Honoraria, Advisory Boards and Speaker\u2019s Bureau for Janssen, Celgene, Bristol-Myers Squibb, and Takeda; Honoraria and Advisory Boards for Amgen.Antonio Palumbo: is currently a Takeda employee, data reported here have been generated during his previous Investigator role, and are not reflecting any Takeda\u2019s position; Ownership interests (including stock options): Takeda; Honoraria and Consultancy for Amgen, Novartis, Bristol-Myers Squibb, Genmab A\/S, Celgene, Janssen-Cilag, Takeda, Sanofi Aventis and Merck; Research funding from: Amgen, Novartis, Bristol-Myers Squibb, Genmab A\/S, Celgene, Janssen-Cilag, Takeda, Sanofi Aventis, Merck and Binding Site; Speakers\u2019 Bureau: Bristol-Myers Squibb.Elena Zamagni: honoraria and member of advisory board for Celgene, Janssen, BMS, Amgen and Takeda.Other authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"127"}}